Wellesley Investment Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $900K | Sell |
25,862
-2,356
| -8% | -$82K | 0.31% | 31 |
|
|
2020
Q2 | $875K | Sell |
28,218
-3,663
| -11% | -$114K | 0.31% | 33 |
|
|
2020
Q1 | $987K | Sell |
31,881
-1,163
| -4% | -$36K | 0.39% | 26 |
|
|
2019
Q4 | $1.23M | Buy |
33,044
+194
| +0.6% | +$7.21K | 0.38% | 28 |
|
|
2019
Q3 | $1.12M | Buy |
32,850
+4,123
| +14% | +$141K | 0.37% | 25 |
|
|
2019
Q2 | $1.18M | Sell |
28,727
-6,935
| -19% | -$285K | 0.41% | 26 |
|
|
2019
Q1 | $1.44M | Buy |
35,662
+92
| +0.3% | +$3.71K | 0.49% | 27 |
|
|
2018
Q4 | $1.47M | Sell |
35,570
-1,879
| -5% | -$77.8K | 0.52% | 25 |
|
|
2018
Q3 | $1.57M | Buy |
37,449
+1,416
| +4% | +$59.2K | 0.51% | 27 |
|
|
2018
Q2 | $1.24M | Buy |
36,033
+884
| +3% | +$30.4K | 0.43% | 38 |
|
|
2018
Q1 | $1.18M | Buy |
35,149
+1,493
| +4% | +$50.2K | 0.43% | 37 |
|
|
2017
Q4 | $1.16M | Buy |
33,656
+2,297
| +7% | +$78.9K | 0.44% | 39 |
|
|
2017
Q3 | $1.06M | Buy |
31,359
+349
| +1% | +$11.8K | 0.44% | 36 |
|
|
2017
Q2 | $988K | Buy |
31,010
+830
| +3% | +$26.4K | 0.42% | 43 |
|
|
2017
Q1 | $979K | Buy |
30,180
+2,427
| +9% | +$78.7K | 0.43% | 40 |
|
|
2016
Q4 | $855K | Buy |
27,753
+4,579
| +20% | +$141K | 0.41% | 41 |
|
|
2016
Q3 | $744K | Sell |
23,174
-927
| -4% | -$29.8K | 0.39% | 43 |
|
|
2016
Q2 | $805K | Sell |
24,101
-251
| -1% | -$8.38K | 0.43% | 28 |
|
|
2016
Q1 | $685K | Buy |
24,352
+3,742
| +18% | +$105K | 0.41% | 37 |
|
|
2015
Q4 | $631K | Buy |
+20,610
| New | +$631K | 0.43% | 34 |
|